Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)

SHA:688016 Revenue

Shanghai MicroPort Endovascular MedTech had revenue of 324.99M CNY in the quarter ending September 30, 2026, with 8.20% growth. This brings the company's total for the last twelve months to 1.45B, up 16.24% year-over-year. In the year 2025, Shanghai MicroPort Endovascular MedTech had annual revenue of 1.35B with 11.96% growth. That makes Shanghai MicroPort Endovascular MedTech the 16,889th largest company in the world by revenue and 3,065th in China.

• Revenue (ttm): 1.45B
• Revenue Growth: +16.24%
• P/S Ratio: 7.17
• Revenue / Employee: 1.77M
• Employees: 859
• Market Cap: 10.43B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 1.09B 81.0%
• Overseas 256.95M 19.0%

Fiscal year ended Dec 31, 2025 See the full SHA:688016 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.35B	144.31M	11.96%
Dec 31, 2024	1.21B	19.12M	1.61%
Dec 31, 2023	1.19B	290.70M	32.43%
Dec 31, 2022	896.50M	211.87M	30.95%
Dec 31, 2021	684.63M	214.38M	45.59%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error